FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

2088911000001101: Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25078101000001111 Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25078201000001116 Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Is a Cabergoline 500microgram tablets 8 tablet true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Is pack of Dostinex 500microgram tablets (Pfizer Ltd) false Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Has active ingredient Cabergoline false Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Has AMP Dostinex 500microgram tablets (Pfizer Ltd) true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Has specific active ingredient Cabergoline true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dostinex 500microgram tablets (Pfizer Ltd) 8 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start